{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T23:16:14Z","timestamp":1768691774855,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.vaccine.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T15:31:20Z","timestamp":1647099080000},"page":"2274-2281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination"],"prefix":"10.1016","volume":"40","author":[{"given":"Antonia","family":"Morga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Rozario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.03.005_b0005","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2022.03.005_b0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/infdis\/jis240","article-title":"Aging population and future burden of pneumococcal pneumonia in the United States","volume":"205","author":"Wroe","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.03.005_b0015","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.15585\/mmwr.mm6846a5","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u226565 years: Updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Matanock","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2022.03.005_b0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/21645515.2020.1780847","article-title":"Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States","volume":"17","author":"Talbird","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2022.03.005_b0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s12879-018-3326-z","article-title":"Clinical and economic burden of pneumococcal disease in US adults aged 19\u201364 years with chronic or immunocompromising diseases: an observational database study","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2022.03.005_b0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12913-016-1432-4","article-title":"Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions","volume":"16","author":"Weycker","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vaccine.2022.03.005_b0035","doi-asserted-by":"crossref","first-page":"338","DOI":"10.12688\/f1000research.22341.1","article-title":"Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections","volume":"9","author":"Feldman","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.vaccine.2022.03.005_b0040","unstructured":"Centers for Disease Control and Prevention. Pneumococcal vaccination among U.S. Medicare beneficiaries aged \u226565 years, 2009\u20132017. 2018. https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/pubs-resources\/pcv13-medicare-beneficiaries.html [Accessed May 4, 2021]."},{"key":"10.1016\/j.vaccine.2022.03.005_b0045","unstructured":"IBM Watson Health IBM MarketScan Research Databases for Health Services Researchers. IBM Corporation 2019. https:\/\/www.ibm.com\/downloads\/cas\/6KNYVVQ2. [Accessed 20 August 2021]."},{"key":"10.1016\/j.vaccine.2022.03.005_b0050","unstructured":"Centers for Disease Control and Prevention. ACIP recommendations. Centers for Disease Control and Prevention; 2021. https:\/\/www.cdc.gov\/vaccines\/acip\/recommendations.html [Accessed July 7, 2021]."},{"key":"10.1016\/j.vaccine.2022.03.005_b0055","unstructured":"US Department of Health and Human Services. Immunization and Infectious Diseases | Healthy People 2020. https:\/\/www.healthypeople.gov\/2020\/topics-objectives\/topic\/immunization-and-infectious-diseases [Accessed July 7, 2021]."},{"issue":"3","key":"10.1016\/j.vaccine.2022.03.005_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of vaccination coverage among adult populations \u2013 United States, 2018","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2022.03.005_b0065","doi-asserted-by":"crossref","first-page":"728","DOI":"10.15585\/mmwr.mm6627a4","volume":"66","author":"Black","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2022.03.005_b0070","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1016\/j.vaccine.2018.10.015","article-title":"Pneumococcal vaccination patterns among persons aged 65 years or older in the United States: a retrospective database analysis","volume":"36","author":"Yang","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.03.005_b0075","unstructured":"CDC ACIP unanimously votes to provisionally recommend Merck\u2019s Vaxneuvance\u2122 (pneumococcal 15-valent conjugate vaccine) in series with Pneumovax\u00ae 23 (pneumococcal vaccine polyvalent) as an option for pneumococcal vaccination in appropriate adults. Merck; 2021. https:\/\/www.merck.com\/news\/cdc-acip-unanimously-votes-to-provisionally-recommend-mercks-vaxneuvance-pneumococcal-15-valent-conjugate-vaccine-in-series-with-pneumovax-23-pneumococcal-vaccine-polyvalen\/ [Accessed October 27, 2021]."},{"key":"10.1016\/j.vaccine.2022.03.005_b0080","unstructured":"Advisory Committee on Immunization Practices votes to recommend routine use of Pfizer's Prevnar 20\u2122 (pneumococcal 20-valent conjugate vaccine) in adults. Pfizer; 2021. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/advisory-committee-immunization-practices-votes-recommend [Accessed October 27, 2021]."},{"issue":"1","key":"10.1016\/j.vaccine.2022.03.005_b0085","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1080\/07853890.2021.2009128","article-title":"Impact of COVID-19 pandemic on routine immunization","volume":"53","author":"Ota","year":"2021","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.vaccine.2022.03.005_b0090","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1370\/afm.2730","article-title":"Silent consequences of COVID-19: why it\u2019s critical to recover routine vaccination rates through equitable vaccine policies and practices","volume":"19","author":"Skolnik","year":"2021","journal-title":"Ann Fam Med"},{"issue":"34","key":"10.1016\/j.vaccine.2022.03.005_b0095","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1016\/j.vaccine.2020.06.069","article-title":"Silver lining of COVID-19: Heightened global interest in pneumococcal and influenza vaccines, an infodemiology study","volume":"38","author":"Paguio","year":"2020","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22002699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22002699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:11:50Z","timestamp":1759403510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22002699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":19,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0264410X22002699"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.005","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}